JA
ALXN

JOYN Advisors’s Alexion Pharmaceuticals ALXN Stock Holding History

JOYN Advisors’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-120
Closed -$12K – 1610
2018
Q4 		$12K Sell
120
-217
-64% -$25.6K ﹤0.01% 905
2018
Q3 		$47K Sell
337
-11
-3% -$1.38K 0.01% 412
2018
Q2 		$43K Buy
348
+245
+238% +$28.6K 0.01% 448
2018
Q1 		$11K Buy
+103
New +$12.3K ﹤0.01% 764

Other funds holding ALXN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

JOYN Advisors's ALXN Position: Q1 2019 in Review

JOYN Advisors sold out of Alexion Pharmaceuticals (ALXN) in Q1 2019, closing a stake of 120 shares — an estimated $12K sold.

JOYN Advisors first reported a position in ALXN in Q1 2018 and held it in 4 quarters. The position peaked at $47K in Q3 2018. 611 funds tracked by Wall St. Rank hold ALXN as of Q1 2019.

  • JOYN Advisors reported no remaining Alexion Pharmaceuticals position as of Q1 2019 after selling out during the quarter.
  • JOYN Advisors sold 120 Alexion Pharmaceuticals shares in Q1 2019, an estimated $12K.
  • JOYN Advisors first reported a position in Alexion Pharmaceuticals in Q1 2018 and held it in 4 quarters.
  • JOYN Advisors's Alexion Pharmaceuticals position peaked at $47K in Q3 2018.
  • 611 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q1 2019.

Based on JOYN Advisors's 13F filing for Q1 2019, filed 9 May 2019.